Endothelin in the female vasculature: A role in aging?

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 298, Issue 3, 2010, Pages

  Lekontseva, Olga ^a   Chakrabarti, Subhadeep ^a   Davidge, Sandra T ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Estrogen; ET 1; Inflammation; Menopause; Vasoconstriction

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR; ESTROGEN;

AGING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; FEMALE; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; HYPERTENSION; PATHOGENESIS; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REVIEW; STROKE;

AGED; AGING; ANIMALS; CARDIOVASCULAR DISEASES; ENDOTHELIN-1; ESTROGENS; FEMALE; HUMANS; VASCULITIS; VASOCONSTRICTION;

EID: 77749328881     PISSN: 03636119     EISSN: 15221490     Source Type: Journal    
DOI: 10.1152/ajpregu.00656.2009     Document Type: Review

References (115)

1. Ajayi AA, Ogungbade GO, Okorodudu AO. Sex hormone regulation of systemic endothelial and renal microvascular reactivity in type-2 diabetes: studies in gonadectomized and sham-operated Zucker diabetic rats. Eur J Clin Invest 34: 349-357, 2004.
2. Akishita M, Kozaki K, Eto M, Yoshizumi M, Ishikawa M, Toba K, Orimo H, Ouchi Y. Estrogen attenuates endothelin-1 production by bovine endothelial cells via estrogen receptor. Biochem Biophys Res Commun 251: 17-21, 1998.
3. Akishita M, Ouchi Y, Miyoshi H, Orimo A, Kozaki K, Eto M, Ishikawa M, Kim S, Toba K, Orimo H. Estrogen inhibits endothelin-1 production and c-fos gene expression in rat aorta. Atherosclerosis 125: 27-38, 1996.
4. Alvarez A, Hermenegildo C, Issekutz AC, Esplugues JV, Sanz MJ. Estrogens inhibit angiotensin II-induced leukocyte-endothelial cell interactions in vivo via rapid endothelial nitric oxide synthase and cyclooxygenase activation. Circ Res 91: 1142-1150, 2002.
5. Anggrahini DW, Emoto N, Nakayama K, Widyantoro B, Adiarto S, Iwasa N, Nonaka H, Rikitake Y, Kisanuki YY, Yanagisawa M, Hirata K. Vascular endothelial cell-derived endothelin-1 mediates vascular inflammation and neointima formation following blood flow cessation. Cardiovasc Res 82: 143-151, 2009.
6. Anwaar I, Rendell M, Gottsater A, Lindgarde F, Hulthen UL, Mattiasson I. Hormone replacement therapy in healthy postmenopausal women. Effects on intraplatelet cyclic guanosine monophosphate, plasma endothelin-1 and neopterin. J Intern Med 247: 463-470, 2000.
7. Ba ZF, Chaudry IH. Role of estrogen receptor subtypes in estrogen-induced organ-specific vasorelaxation after trauma-hemorrhage. Am J Physiol Heart Circ Physiol 295: H2061-H2067, 2008.
8. Ba ZF, Lu A, Shimizu T, Szalay L, Schwacha MG, Rue LW 3rd, Bland KI, Chaudry IH. 17β-Estradiol modulates vasoconstriction induced by endothelin-1 following trauma-hemorrhage. Am J Physiol Heart Circ Physiol 292: H245-H250, 2007.
9. Bacon CR, Cary NR, Davenport AP. Endothelin peptide and receptors in human atherosclerotic coronary artery and aorta. Circ Res 79: 794-801, 1996.
10. Barton M, Cosentino F, Brandes RP, Moreau P, Shaw S, Luscher TF. Anatomic heterogeneity of vascular aging: role of nitric oxide and endothelin. Hypertension 30: 817-824, 1997.
11. Best PJ, Berger PB, Miller VM, Lerman A. The effect of estrogen replacement therapy on plasma nitric oxide and endothelin-1 levels in postmenopausal women. Ann Intern Med 128: 285-288, 1998.
12. Blacher J, Safar ME. Large-artery stiffness, hypertension and cardiovascular risk in older patients. Nat Clin Pract Cardiovasc Med 2: 450-455, 2005.
13. Bohm F, Settergren M, Pernow J. Vitamin C blocks vascular dysfunction and release of interleukin-6 induced by endothelin-1 in humans in vivo. Atherosclerosis 190: 408-415, 2007.
14. Brandes RP, Fleming I, Busse R. Endothelial aging. Cardiovasc Res 66: 286-294, 2005.
15. Celermajer DS, Sorensen KE, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Deanfield JE. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J Am Coll Cardiol 24: 471-476, 1994.
16. Chakrabarti S, Lekontseva O, Davidge ST. Estrogen is a modulator of vascular inflammation. IUBMB Life 60: 376-382, 2008.
17. Chen DB, Bird IM, Zheng J, Magness RR. Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells. Endocrinology 145: 113-125, 2004.
18. Costopoulos C, Liew TV, Bennett M. Ageing and atherosclerosis: mechanisms and therapeutic options. Biochem Pharmacol 75: 1251-1261, 2008.
19. Coylewright M, Reckelhoff JF, Ouyang P. Menopause and hypertension: an age-old debate. Hypertension 51: 952-959, 2008.
20. Creatsas GC, Malamitsi-Puchner AB, Hassan EA, Economou EB, Aravantinos DI. Endothelin plasma levels in primary amenorrheic adolescents before and after estrogen treatment. J Soc Gynecol Investig 3: 350-353, 1996.
21. Csiszar A, Wang M, Lakatta EG, Ungvari Z. Inflammation and endothelial dysfunction during aging: role of NF-κB. J Appl Physiol 105: 1333-1341, 2008.
22. Dammanahalli KJ, Sun Z. Endothelins and NADPH oxidases in the cardiovascular system. Clin Exp Pharmacol Physiol 35: 2-6, 2008.
23. Dantas AP, Franco Mdo C, Silva-Antonialli MM, Tostes RC, Fortes ZB, Nigro D, Carvalho MH. Gender differences in superoxide generation in microvessels of hypertensive rats: role of NAD(P)H-oxidase. Cardiovasc Res 61: 22-29, 2004.
24. David FL, Carvalho MH, Cobra AL, Nigro D, Fortes ZB, Reboucas NA, Tostes RC. Ovarian hormones modulate endothelin-1 vascular reactivity and mRNA expression in DOCA-salt hypertensive rats. Hypertension 38: 692-696, 2001.
25. Donato AJ, Gano LB, Eskurza I, Silver AE, Gates PE, Jablonski K, Seals DR. Vascular endothelial dysfunction with aging: endothelin-1 and endothelial nitric oxide synthase. Am J Physiol Heart Circ Physiol 297: H425-H432, 2009.
26. Dubey RK, Jackson EK, Keller PJ, Imthurn B, Rosselli M. Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism. Hypertension 37: 640-644, 2001.
27. Dupuis J. Endothelin receptor antagonists and their developing role in cardiovascular therapeutics. Can J Cardiol 16: 903-910, 2000.
28. Ebihara I, Nakamura T, Takahashi T, Tomino Y, Shimada N, Koide H. Increased endothelin-1 mRNA expression in peripheral blood monocytes of dialysis patients. Perit Dial Int 17: 595-601, 1997.
29. Emoto N, Yanagisawa M. Endothelin-converting enzyme-2 is a membrane-bound, phosphoramidon-sensitive metalloprotease with acidic pH optimum. J Biol Chem 270: 15262-15268, 1995.
30. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol 15: 1983-1992, 2004.
31. Ergul A, Shoemaker K, Puett D, Tackett RL. Gender differences in the expression of endothelin receptors in human saphenous veins in vitro. J Pharmacol Exp Ther 285: 511-517, 1998.
32. Evans MJ, Harris HA, Miller CP, Karathanasis SK, Adelman SJ. Estrogen receptors alpha and beta have similar activities in multiple endothelial cell pathways. Endocrinology 143: 3785-3795, 2002.
33. Fernandez-Patron C, Radomski MW, Davidge ST. Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor. Circ Res 85: 906-911, 1999.
34. Gates PE, Strain WD, Shore AC. Human endothelial function and microvascular ageing. Exp Physiol 94: 311-316, 2009.
35. Giachini FR, Callera GE, Carneiro FS, Tostes RC, Webb RC. Therapeutic targets in hypertension: is there a place for antagonists of the most potent vasoconstrictors? Expert Opin Ther Targets 12: 327-339, 2008.
36. Goettsch W, Lattmann T, Amann K, Szibor M, Morawietz H, Munter K, Muller SP, Shaw S, Barton M. Increased expression of endothelin-1 and inducible nitric oxide synthase isoform II in aging arteries in vivo: implications for atherosclerosis. Biochem Biophys Res Commun 280: 908-913, 2001.
37. Gragasin FS, Xu Y, Arenas IA, Kainth N, Davidge ST. Estrogen reduces angiotensin II-induced nitric oxide synthase and NAD(P)H oxidase expression in endothelial cells. Arterioscler Thromb Vasc Biol 23: 38-44, 2003.
38. Hai E, Ikura Y, Naruko T, Shirai N, Yoshimi N, Kayo S, Sugama Y, Fujino H, Ohsawa M, Tanzawa K, Yokota T, Ueda M. Alterations of endothelin-converting enzyme expression in early and advanced stages of human coronary atherosclerosis. Int J Mol Med 13: 649-654, 2004.
39. Heigl A, Lachat M, Lattmann T, Luscher T, Barton M. Acute effects of 17β-oestradiol on functional activity of endothelin-converting enzymes in human arteries and veins. Clin Sci (Lond) 103, Suppl 48: 438S-441S, 2002.
40. Hennig B, Toborek M, McClain CJ, Diana JN. Nutritional implications in vascular endothelial cell metabolism. J Am Coll Nutr 15: 345-358, 1996.
41. Hernandez-Perera O, Perez-Sala D, Navarro-Antolin J, Sanchez-Pascuala R, Hernandez G, Diaz C, Lamas S. Effects of the 3-hydroxy-3-methylglutaryl- CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest 101: 2711-2719, 1998.
42. B receptors for endothelin induces hypertension in the hamster. Am J Physiol Heart Circ Physiol 289: H1258-H1264, 2005.
43. Hynynen MM, Khalil RA. The vascular endothelin system in hypertension-recent patents and discoveries. Recent Pat Cardiovasc Drug Discov 1: 95-108, 2006.
44. Ihling C, Bohrmann B, Schaefer HE, Technau-Ihling K, Loeffler BM. Endothelin-1 and endothelin converting enzyme-1 in human atherosclerosis-novel targets for pharmacotherapy in atherosclerosis. Curr Vasc Pharmacol 2: 249-258, 2004.
45. Ihling C, Gobel HR, Lippoldt A, Wessels S, Paul M, Schaefer HE, Zeiher AM. Endothelin-1-like immunoreactivity in human atherosclerotic coronary tissue: a detailed analysis of the cellular distribution of endothelin-1. J Pathol 179: 303-308, 1996.
46. Ikura T, Sawamura T, Shiraki T, Hosokawa H, Kido T, Hoshikawa H, Shimada K, Tanzawa K, Kobayashi S, Miwa S. cDNA cloning and expression of bovine endothelin converting enzyme. Biochem Biophys Res Commun 203: 1417-1422, 1994.
47. Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86: 2863-2867, 1989.
48. Ishihata A, Katano Y. Investigation of differentially expressed genes in the ventricular myocardium of senescent rats. Ann NY Acad Sci 1067: 142-151, 2006.
49. Juan SH, Chen JJ, Chen CH, Lin H, Cheng CF, Liu JC, Hsieh MH, Chen YL, Chao HH, Chen TH, Chan P, Cheng TH. 17β-Estradiol inhibits cyclic strain-induced endothelin-1 gene expression within vascular endothelial cells. Am J Physiol Heart Circ Physiol 287: H1254-H1261, 2004.
50. Kahler J, Ewert A, Weckmuller J, Stobbe S, Mittmann C, Koster R, Paul M, Meinertz T, Munzel T. Oxidative stress increases endothelin-1 synthesis in human coronary artery smooth muscle cells. J Cardiovasc Pharmacol 38: 49-57, 2001.
51. Kannel WB. Hypertension as a risk factor for cardiac events - epidemiologic results of long-term studies. J Cardiovasc Pharmacol 21, Suppl 2: S27-S37, 1993.
52. Kawaguchi Y, Suzuki K, Hara M, Hidaka T, Ishizuka T, Kawagoe M, Nakamura H. Increased endothelin-1 production in fibroblasts derived from patients with systemic sclerosis. Ann Rheum Dis 53: 506-510, 1994.
53. Kumazaki T, Wadhwa R, Kaul SC, Mitsui Y. Expression of endothelin, fibronectin, and mortalin as aging and mortality markers. Exp Gerontol 32: 95-103, 1997.
54. Lee KJ, Kim MK, Park YH, Seol HJ, Lim JE, Lee JN, Oh MJ. Vascular endothelial growth factor induces endothelin-1 production via matrix metalloproteinase-2 rather than endothelin-converting enzyme-1. Hypertens Pregnancy 26: 189-199, 2007.
55. Lekontseva O, Jiang Y, Davidge ST. Estrogen replacement increases matrix metalloproteinase contribution to vasoconstriction in a rat model of menopause. J Hypertens 27: 1602-1608, 2009.
56. Lewis SJ. Cardiovascular disease in postmenopausal women: myths and reality. Am J Cardiol 89: 5E-10E; discussion 10E-11E, 2002.
57. Maeda S, Tanabe T, Miyauchi T, Otsuki T, Sugawara J, Iemitsu M, Kuno S, Ajisaka R, Yamaguchi I, Matsuda M. Aerobic exercise training reduces plasma endothelin-1 concentration in older women. J Appl Physiol 95: 336-341, 2003.
58. Marsden PA, Brenner BM. Transcriptional regulation of the endothelin-1 gene by TNF-. Am J Physiol Cell Physiol 262: C854-C861, 1992.
59. Masaki T. Historical review: endothelin. Trends Pharmacol Sci 25: 219-224, 2004.
60. Maturana MA, Breda V, Lhullier F, Spritzer PM. Relationship between endogenous testosterone and cardiovascular risk in early post-menopausal women. Metabolism 57: 961-965, 2008.
61. Mikkola T, Viinikka L, Ylikorkala O. Estrogen and postmenopausal estrogen/progestin therapy: effect on endothelium-dependent prostacyclin, nitric oxide and endothelin-1 production. Eur J Obstet Gynecol Reprod Biol 79: 75-82, 1998.
62. Miller AA, Drummond GR, Mast AE, Schmidt HH, Sobey CG. Effect of gender on NADPH-oxidase activity, expression, and function in the cerebral circulation: role of estrogen. Stroke 38: 2142-2149, 2007.
63. Miller VM, Barber DA, Fenton AM, Wang X, Sieck GC. Gender differences in response to endothelin-1 in coronary arteries: transcription, receptors and calcium regulation. Clin Exp Pharmacol Physiol 23: 256-259, 1996.
64. Miller VM, Mulvagh SL. Sex steroids and endothelial function: translating basic science to clinical practice. Trends Pharmacol Sci 28: 263-270, 2007.
65. Minamino T, Miyauchi H, Yoshida T, Ishida Y, Yoshida H, Komuro I. Endothelial cell senescence in human atherosclerosis: role of telomere in endothelial dysfunction. Circulation 105: 1541-1544, 2002.
66. Montezano AC, Callera GE, Mota AL, Fortes ZB, Nigro D, Carvalho MH, Zorn TM, Tostes RC. Endothelin-1 contributes to the sexual differences in renal damage in DOCA-salt rats. Peptides 26: 1454-1462, 2005.
67. Morawietz H, Duerrschmidt N, Niemann B, Galle J, Sawamura T, Holtz J. Augmented endothelial uptake of oxidized low-density lipoprotein in response to endothelin-1. Clin Sci (Lond) 103, Suppl 48: 9S-12S, 2002.
68. Morawietz H, Talanow R, Szibor M, Rueckschloss U, Schubert A, Bartling B, Darmer D, Holtz J. Regulation of the endothelin system by shear stress in human endothelial cells. J Physiol 525: 761-770, 2000.
69. Morey AK, Razandi M, Pedram A, Hu RM, Prins BA, Levin ER. Oestrogen and progesterone inhibit the stimulated production of endothelin-1. Biochem J 330: 1097-1105, 1998.
70. Mourad JJ, du Cailar G, Nazal EM, Safar ME, Mimran A. Age-related increase of pulse pressure and plasminogen activator inhibitor-1 I/D gene polymorphism in essential hypertension. J Intern Med 257: 93-99, 2005.
71. Mraiche F, Cena J, Das D, Vollrath B. Effects of statins on vascular function of endothelin-1. Br J Pharmacol 144: 715-726, 2005.
72. Murakoshi N, Miyauchi T, Kakinuma Y, Ohuchi T, Goto K, Yanagisawa M, Yamaguchi I. Vascular endothelin-B receptor system in vivo plays a favorable inhibitory role in vascular remodeling after injury revealed by endothelin-B receptor-knockout mice. Circulation 106: 1991-1998, 2002.
73. Niemann B, Rohrbach S, Catar RA, Muller G, Barton M, Morawietz H. Native and oxidized low-density lipoproteins stimulate endothelin-converting enzyme-1 expression in human endothelial cells. Biochem Biophys Res Commun 334: 747-753, 2005.
74. Nilsson UW, Dabrosin C. Estradiol and tamoxifen regulate endostatin generation via matrix metalloproteinase activity in breast cancer in vivo. Cancer Res 66: 4789-4794, 2006.
75. Nuedling S, van Eickels M, Allera A, Doevendans P, Meyer R, Vetter H, Grohe C. 17β-Estradiol regulates the expression of endothelin receptor type B in the heart. Br J Pharmacol 140: 195-201, 2003.
76. Orshal JM, Khalil RA. Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol 286: R233-R249, 2004.
77. Ortmann J, Amann K, Brandes RP, Kretzler M, Munter K, Parekh N, Traupe T, Lange M, Lattmann T, Barton M. Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition. Hypertension 44: 974-981, 2004.
78. Pedersen SH, Nielsen LB, Mortensen A, Nilas L, Ottesen B. Progestins oppose the effects of estradiol on the endothelin-1 receptor type B in coronary arteries from ovariectomized hyperlipidemic rabbits. Menopause 15: 503-510, 2008.
79. A mRNA expression in the aorta of ovariectomised New Zealand White rabbits. Gynecol Endocrinol 25: 175-182, 2009.
80. Polderman KH, Stehouwer CD, van Kamp GJ, Dekker GA, Verheugt FW, Gooren LJ. Influence of sex hormones on plasma endothelin levels. Ann Intern Med 118: 429-432, 1993.
81. Qiao X, McConnell KR, Khalil RA. Sex steroids and vascular responses in hypertension and aging. Gend Med 5, Suppl A: S46-S64, 2008.
82. Ramzy D, Rao V, Tumiati LC, Xu N, Miriuka S, Delgado D, Ross HJ. Role of endothelin-1 and nitric oxide bioavailability in transplant-related vascular injury: comparative effects of rapamycin and cyclosporine. Circulation 114: I214 -I219, 2006.
83. Ramzy D, Rao V, Tumiati LC, Xu N, Sheshgiri R, Miriuka S, Delgado DH, Ross HJ. Elevated endothelin-1 levels impair nitric oxide homeostasis through a PKC-dependent pathway. Circulation 114: I319-I326, 2006.
84. Rao RM, Yang L, Garcia-Cardena G, Luscinskas FW. Endothelialdependent mechanisms of leukocyte recruitment to the vascular wall. Circ Res 101: 234-247, 2007.
85. Reckelhoff JF. Sex steroids, cardiovascular disease, and hypertension: unanswered questions and some speculations. Hypertension 45: 170-174, 2005.
86. Rodrigo MC, Martin DS, Eyster KM. Vascular ECE-1 mRNA expression decreases in response to estrogens. Life Sci 73: 2973-2983, 2003.
87. Rondaij MG, Bierings R, Kragt A, van Mourik JA, Voorberg J. Dynamics and plasticity of Weibel-Palade bodies in endothelial cells. Arterioscler Thromb Vasc Biol 26: 1002-1007, 2006.
88. Ruef J, Moser M, Kubler W, Bode C. Induction of endothelin-1 expression by oxidative stress in vascular smooth muscle cells. Cardiovasc Pathol 10: 311-315, 2001.
89. Russell KS, Haynes MP, Sinha D, Clerisme E, Bender JR. Human vascular endothelial cells contain membrane binding sites for estradiol, which mediate rapid intracellular signaling. Proc Natl Acad Sci USA 97: 5930-5935, 2000.
90. Schiffrin EL, Turgeon A, Deng LY. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats. Br J Pharmacol 121: 935-940, 1997.
91. Stauffer BL, Westby CM, DeSouza CA. Endothelin-1, aging and hypertension. Curr Opin Cardiol 23: 350-355, 2008.
92. Stork S, van der Schouw YT, Grobbee DE, Bots ML. Estrogen, inflammation and cardiovascular risk in women: a critical appraisal. Trends Endocrinol Metab 15: 66-72, 2004.
93. Sudhir K, Ko E, Zellner C, Wong HE, Hutchison SJ, Chou TM, Chatterjee K. Physiological concentrations of estradiol attenuate endothelin 1-induced coronary vasoconstriction in vivo. Circulation 96: 3626-3632, 1997.
94. Tan E, Gurjar MV, Sharma RV, Bhalla RC. Estrogen receptor-α gene transfer into bovine aortic endothelial cells induces eNOS gene expression and inhibits cell migration. Cardiovasc Res 43: 788-797, 1999.
95. Tan Z, Wang TH, Yang D, Fu XD, Pan JY. Mechanisms of 17β-estradiol on the production of ET-1 in ovariectomized rats. Life Sci 73: 2665-2674, 2003.
96. Taner CB, Severson SR, Best PJ, Lerman A, Miller VM. Treatment with endothelin-receptor antagonists increases NOS activity in hypercholesterolemia. J Appl Physiol 90: 816-820, 2001.
97. Tostes RC, David FL, Carvalho MH, Nigro D, Scivoletto R, Fortes ZB. Gender differences in vascular reactivity to endothelin-1 in deoxycorticosterone-salt hypertensive rats. J Cardiovasc Pharmacol 36: S99-S101, 2000.
98. Ungvari Z, Orosz Z, Labinskyy N, Rivera A, Xiangmin Z, Smith K, Csiszar A. Increased mitochondrial H2O2 production promotes endothelial NF-κB activation in aged rat arteries. Am J Physiol Heart Circ Physiol 293: H37-H47, 2007.
99. Van Guilder GP, Westby CM, Greiner JJ, Stauffer BL, DeSouza CA. Endothelin-1 vasoconstrictor tone increases with age in healthy men but can be reduced by regular aerobic exercise. Hypertension 50: 403-409, 2007.
100. van Kesteren PJ, Kooistra T, Lansink M, van Kamp GJ, Asscheman H, Gooren LJ, Emeis JJ, Vischer UM, Stehouwer CD. The effects of sex steroids on plasma levels of marker proteins of endothelial cell functioning. Thromb Haemost 79: 1029-1033, 1998.
101. Wahl JR, Goetsch NJ, Young HJ, Van Maanen RJ, Johnson JD, Pea AS, Brittingham A. Murine macrophages produce endothelin-1 after microbial stimulation. Exp Biol Med (Maywood) 230: 652-658, 2005.
102. Wang X, Barber DA, Lewis DA, McGregor CG, Sieck GC, Fitzpatrick LA, Miller VM. Gender and transcriptional regulation of NO synthase and ET-1 in porcine aortic endothelial cells. Am J Physiol Heart Circ Physiol 273: H1962-H1967, 1997.
103. Wilbert-Lampen U, Seliger C, Trapp A, Straube F, Plasse A. Female sex hormones decrease constitutive endothelin-1 release via endothelial sigma-1/cocaine receptors: an action independent of the steroid hormone receptors. Endothelium 12: 185-191, 2005.
104. Wilcox JG, Hatch IE, Gentzschein E, Stanczyk FZ, Lobo RA. Endothelin levels decrease after oral and nonoral estrogen in postmenopausal women with increased cardiovascular risk factors. Fertil Steril 67: 273-277, 1997.
105. Willcox JK, Ash SL, Catignani GL. Antioxidants and prevention of chronic disease. Crit Rev Food Sci Nutr 44: 275-295, 2004.
106. Wingrove CS, Stevenson JC. 17β-Oestradiol inhibits stimulated endothelin release in human vascular endothelial cells. Eur J Endocrinol 137: 205-208, 1997.
107. Wypij DM, Nichols JS, Novak PJ, Stacy DL, Berman J, Wiseman JS. Role of mast cell chymase in the extracellular processing of bigendothelin-1 to endothelin-1 in the perfused rat lung. Biochem Pharmacol 43: 845-853, 1992.
108. Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, Yanagisawa M. ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78: 473-485, 1994.
109. Xu H, Duan J, Wang W, Dai S, Wu Y, Sun R, Ren J. Reactive oxygen species mediate oxidized low-density lipoprotein-induced endothelin-1 gene expression via extracellular signal-regulated kinase in vascular endothelial cells. J Hypertens 26: 956-963, 2008.
110. Yamamoto K, Ikeda U, Mito H, Fujikawa H, Sekiguchi H, Shimada K. Endothelin production in pulmonary circulation of patients with mitral stenosis. Circulation 89: 2093-2098, 1994.
111. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, Yazaki Y, Goto K, Masaki T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 332: 411-415, 1988.
112. Yanes LL, Romero DG, Cucchiarelli VE, Fortepiani LA, Gomez-Sanchez CE, Santacruz F, Reckelhoff JF. Role of endothelin in mediating postmenopausal hypertension in a rat model. Am J Physiol Regul Integr Comp Physiol 288: R229-R233, 2005.
113. Yang YM, Huang A, Kaley G, Sun D. eNOS uncoupling and endothelial dysfunction in aged vessels. Am J Physiol Heart Circ Physiol 297: H1829-H1836, 2009.
114. Ylikorkala O, Orpana A, Puolakka J, Pyorala T, Viinikka L. Postmenopausal hormonal replacement decreases plasma levels of endothelin-1. J Clin Endocrinol Metab 80: 3384-3387, 1995.
115. Yoshizumi M, Kurihara H, Morita T, Yamashita T, Oh-hashi Y, Sugiyama T, Takaku F, Yanagisawa M, Masaki T, Yazaki Y. Interleukin 1 increases the production of endothelin-1 by cultured endothelial cells. Biochem Biophys Res Commun 166: 324-329, 1990.